Christopher Arbeiter-Grimus

[Inari, now part of Stryker @InariMedical]

#FLAME RESULTS PUBLISHED! The largest prospective study of interventional treatment in high-risk #pulmonaryembolism shows 1.9% all-cause in-hospital mortality for patients treated with #FlowTriever.

More: https://t.co/h2COfavRnC

[Christopher Arbeiter-Grimus @x2ver]

Today is the day!

#DGKHerztage

[Christopher Arbeiter-Grimus @x2ver]

Ist es an der Zeit die #Lungenembolie pro-aktiv statt reaktiv zu managen?

Neue Einsichten in aktuelle Entwicklungen auf den #DGKHerztage2023 von @GFurnau, Dr. M. Veddeler, @RammosChristos und @FelixMahfoud unter dem Vorsitz von Prof. Ch. Tiefenbacher und Prof. A. Staudt.

[Inari, now part of Stryker @InariMedical]

As the latest representation of Inari's commitment to clinical evidence, we are proud to share the planned enrollment of the #PEERLESS II trial, a prospective, global, multi-center RCT comparing the outcomes of #PE patients treated with the #FlowTriever system vs #anticoagulation alone: https://t.co/w2ZrIfx5ec

[Christopher Arbeiter-Grimus @x2ver]

Inari auf den DGK-Herztagen: Im Untergeschoß nahe dem Poster-Area
#dgkherztage

[Christopher Arbeiter-Grimus @x2ver]

Ist es an der Zeit die #Lungenembolie pro-aktiv statt reaktiv zu managen?

Neue Einsichten in aktuelle Entwicklungen auf den #DGKHerztage2023 von @GFurnau, Dr. M. Veddeler, @RammosChristos und @FelixMahfoud unter dem Vorsitz von Prof. Ch. Tiefenbacher und Prof. A. Staudt.

[Keith Pereira MD, #VIrad @keithppereira]

#IRad 📞 #IRad

'I have a PE and would like to get catheter directed therapy'

'Sure, What's the patient's name and DOB?'

'I, am the patient'

Thank you Dr. Ilan Raoli for sharing your #PulmonaryEmbolism journey with us at #MidwestPE23. So glad you are back to normal life!

[Inari, now part of Stryker @InariMedical]

For decades, high-risk PE mortality has been >25% in historical data. #FLAME reports 1.9% mortality w/ #FlowTriever, demonstrating the benefits of developing a systematic approach to improve PE patient outcomes.

Join our upcoming webinar to learn more: https://t.co/taeR9eXtXF

[Inari, now part of Stryker @InariMedical]

Congratulations to @melsharabasssy & the entire team at Marien-Hospital Wesel for a successful first #FlowSaver case in #EMEA!

[Christopher Arbeiter-Grimus @x2ver]

Thanks for sharing your faith so openly @vanessabusch! It’s important to put a spotlight on #pulmonaryembolism and work on effective therapies that not only allow for survival but for a life post #pe.

[Vanessa Buschschlüter @vanessabusch]

But on a more existential level: this was my first duty trip after suffering a massive pulmonary embolism in December 2021. @RoyalLondonHosp was there for me and @xraysurgeon used the @InariMedical FlowTriever to hoover up my clots.

[Inari, now part of Stryker @InariMedical]

Happening at #PERT2022:
The Future of Treating Acute PE: Uncovering Challenges with Risk Stratification and Late-Breaking Clinical Data w/ Drs. @vic_tapson, Mitch Silver, @ParthRali, Hamid Mojibian, & @wissamj123.

🗓️ Friday, Sept 30 | 11:50am ET

#pulmonaryembolism #VTE

[Radcliffe Cardiology @radcliffeCARDIO]

ESC 2022 LIVE Satellite Symposium – Treatment of acute #PE with no lytics? What is the option?

Hear from the experts ➡️ Profs Stefan Stortecky, Felix Mahfoud and Nils Kucher on 26 August at 12:45 CET 👉
https://t.co/VTQSmkcIF4

Get involved in Barcelona! 🇪🇸
@InariMedical

[Christopher Arbeiter-Grimus @x2ver]

In Vienna at #ECR2022? Stop by at "The Cube" (floor -2 H) to meet us there!

#interventionalradiology #deepveinthrombosis #clottriever #pulmonaryembolism #pulmonarythrombectomy #flowtriever

[Inari, now part of Stryker @InariMedical]

Interested in learning more about #ClotTriever and #FlowTriever for treating acute #DVT and #PE? Join us at #ECR2022 and learn at "The Cube" Innovation and hands-on sessions. See you there!

[Christopher Arbeiter-Grimus @x2ver]

LAE Notfallsbehandlungen, COVID und knappe ICU Ressourcen: Prof. Bernhard Gebauer (Charité Berlin) und @FelixMahfoud (UK Saarlandes) teilen Ihre Erfahrungen mit dem #FlowTriever und diskutieren mit @InariMedical CMO Dr. Thomas Tu, MD die vorhandenen klinischen Daten!

[Inari, now part of Stryker @InariMedical]

Upcoming #ClotWarriorAcademy: What if there was a way to treat #PulmonaryEmbolism patients without the need for #ICU stay? What is crucial for #PE treatment during #COVID19? Join Thursday, Dec 16 to learn more. Register: https://t.co/OIygTunT78

[Christopher Arbeiter-Grimus @x2ver]

Who wouldn't like to spare the ICU and go Christmas tree instead? Congratulations!

[Cliff Raymond, MD @CliffRaymondMD]

Another great #PE pull with @InariMedical Flowtriever. Straight back to a med floor from our IR table. No ICU stay needed 💪🏼. And the best part is that grandma will live to see another good Christmas with her grandchildren 🙏🏼 @SIRRFS #radres #radiology

[Christopher Arbeiter-Grimus @x2ver]

@ArminWolf Time Capsule. Da soll noch einer sagen Apples Produktnamen wären pathetisch.

[Christopher Arbeiter-Grimus @x2ver]

Biggest registry on a PE therapy suggests that
- it doesn't require #ICU overnight stay post procedure for >60% of patients
- 96.2% of patients don't need adjunctive therapy

Let's provide safe and effective PE treatment during COVID times and limited #ICU resources!

[Inari, now part of Stryker @InariMedical]

Interim results for #FLASH500 show that #PE patients benefit from #clot removal with Inari #FlowTriever without the need for thrombolytics or consequent #ICU. For hospitals, this means minimized resource utilization. Learn more: https://t.co/QY7BJhbX9b

[Inari, now part of Stryker @InariMedical]

There's still time to register! Join us & @PERTConsortium tomorrow for "#BloodlessThrombectomy for #PulmonaryEmbolism: Evidence and Future Direction."

📅 11/23 7 pm ET

Register: https://t.co/3nOOzmO5IT

[Christopher Arbeiter-Grimus @x2ver]

Dr. Lichtenberg to share European experience with the #clottriever with US docs at the #VEITHsymposium!
Thank you to all European physicians who trust into @InariMedical to move the boundaries of interventional #vte treatment! It’s rewarding to work with you and impactful!

[Inari, now part of Stryker @InariMedical]

Visit us at the #VEITHsymposium next week! Be sure to stop by booth 308 to meet the Inari Medical team. Check out several learning opportunities happening here: https://t.co/FB9cdP1PO3

[Christopher Arbeiter-Grimus @x2ver]

Interesting news in times of rapidly filling ICU beds for #pulmonaryembolism patients!

[Inari, now part of Stryker @InariMedical]

A recent study evaluating elevated risk patients with #PE found treatment with #FlowTriever significantly reduced in-hospital mortality and #ICU length of stay compared to routine care. More: https://t.co/Zi65j40eAv

[Inari, now part of Stryker @InariMedical]

It's not too late to register!

3 chances to tune in for a special #FLASH500 #ClotWarriorAcademy event with @Thomas_TuMD & @CatalinPToma!

Tune in TODAY, register here: https://t.co/7DRpACXPDG